Sorafenib Improves Survival in Hepatocellular Carcinoma: Results of a Phase 3 Randomized, Placebo-Controlled Trial

Article Information

DOI 
http://dx.doi.org/10.1177/155989770700700303
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2007 MD Conference Express

Author Information

  1. Caroline Helwick
  1. Josep M. Llovet, MD
    1. Mount Sinai School of Medicine, New York, New York, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015100
Jul 2015011
Aug 2015100
Oct 2015332
Nov 2015144
Total1187

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Sorafenib Improves Survival in Hepatocellular Carcinoma: Results of a Phase 3 Randomized, Placebo-Controlled Trial
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Gastrointestinal Cancers Clinical Trials